SCMP - Sucampo Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Delayed price. Currency in USD
10.55
+0.20 (+1.93%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous close10.35
Open10.25
Bid9.95 x 100
Ask12.95 x 1400
Day's range10.25 - 10.55
52-week range9.30 - 17.55
Volume371,857
Avg. volume529,262
Market cap489.62M
Beta0.74
PE ratio (TTM)N/A
EPS (TTM)-3.49
Earnings date7 Nov 2017 - 13 Nov 2017
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est16.06
Trade prices are not sourced from all markets
  • Incyte (INCY) Initiates Essential Thrombocythemia Trial
    Zacks4 days ago

    Incyte (INCY) Initiates Essential Thrombocythemia Trial

    Incyte (INCY) announced that the first patient has been treated in the essential thrombocythemia trial on ruxolitinib. A potential label expansion of the drug will boost sales.

  • Achillion (ACHN) Shares Down as J&J Announces Stake Sale
    Zacks5 days ago

    Achillion (ACHN) Shares Down as J&J Announces Stake Sale

    Achillion's (ACHN) shares fell following the announcement that J&J will sell its complete stake in the company.

  • Valeant (VRX) Announces Pricing of Senior Secured Notes
    Zacks5 days ago

    Valeant (VRX) Announces Pricing of Senior Secured Notes

    Valeant (VRX) prices its senior secured notes. The proceeds of the notes will be used to pay down its existing debt.

  • Roche (RHHBY) Receives FDA Clearance for Ventana MMR Test
    Zacks5 days ago

    Roche (RHHBY) Receives FDA Clearance for Ventana MMR Test

    Roche's (RHHBY) diagnostic portfolio gets a further boost with FDA's clearance for Ventana tests.

  • Pacira's Exparel sNDA to be Reviewed by FDA Advisory Committee
    Zacks5 days ago

    Pacira's Exparel sNDA to be Reviewed by FDA Advisory Committee

    Pacira (PCRX) announced that the FDA has asked for an Advisory Committee Meeting to review the supplemental New Drug Application for expanded indication of Exparel in the nerve block setting.

  • Cardinal Health (CAH) to Divest Assets to Shanghai Pharma
    Zacks5 days ago

    Cardinal Health (CAH) to Divest Assets to Shanghai Pharma

    Cardinal Health (CAH) will streamline its Chinese operations by disposing pharmaceutical and medical products distribution business in China.

  • Sucampo (SCMP) Beats on Q3 Earnings & Revenues, Ups '17 View
    Zacks18 days ago

    Sucampo (SCMP) Beats on Q3 Earnings & Revenues, Ups '17 View

    Sucampo Pharmaceuticals' (SCMP) Amitizia recorded strong sales in the United States and Japan, which drove the company's top line in Q3. The company is also working on expanding its Amitizia's label.

  • Associated Press19 days ago

    Sucampo tops 3Q revenue forecasts

    On a per-share basis, the Rockville, Maryland-based company said it had profit of 19 cents. Earnings, adjusted for one-time gains and costs, came to 27 cents per share. The biopharmaceutical company posted ...

  • EQS Group8 months ago

    Sucampo Acquires Vtesse Inc.

    DGAP-News: Sucampo Pharmaceuticals, Inc.03.04.2017 / 12:30 The issuer is solely responsible for the content of this announcement.Transaction Valued at $200 Million UpfrontDiversifies Pipeline with Late Stage Program in Niemann-Pick Disease Type C1 (NPC-1)Increases Company Focus on Specialized Diseases with High Unmet NeedLeverages Focus on Orphan and Pediatric DiseasesExpected to be Accretive to Earnings Beginning in 2019Shareholders and Investors of Sucampo and Vtesse to Establish Foundation to Support Research Related to NPC DiseaseCompany to Host Conference Call Today at 8:30 a.m. ...

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes